I know the study schedule has the 12 month report for first 5 patients due till the end of the year which could considerably impact on SP ( and of course company achievement) - which is 5-6 months and can be a long time and much can happen....looking more recently, the second group of subjects (patients) were implanted with valves (reported may 31) reported as being completed 'last week'....which is about 4 weeks ago (give or take)...and close to the 30 days for the first report for the second patient group. So, the 30 days report from the second group in the next few weeks, and the 12 month report for the first group around the same time as the (informal) 6 month report from the second group in about 6 months.......with the potential for FDA application.....it could be a very exciting 6 months .......... lots of news and steps closer to the end goal.
just my 2 cents worth.
AVR Price at posting:
$23.00 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)